Maprotiline information

Maprotiline
Clinical data
Trade names	Ludiomil, others
Other names	Maprotiline hydrochloride; Maprotiline methanesulfonate; Ba 34276
AHFS/Drugs.com	Monograph
MedlinePlus	a682158
Routes of; administration	Oral, intramuscular, intravenous
ATC code	N06AA21 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only); BR: Class C1 (Other controlled substances); US: ℞-only;
Pharmacokinetic data
Bioavailability	66–70%
Protein binding	88%
Metabolism	hepatic
Onset of action	6 hours
Elimination half-life	27–58 hours
Excretion	Urine (57%) and bile (30%) as glucuronides, 3–4% as unchanged drug
Identifiers
	IUPAC name N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine;
CAS Number	10262-69-8 ; 10347-81-6 (hydrochloride); 58902-67-3 (mesylate);
PubChem CID	4011;
IUPHAR/BPS	2402;
DrugBank	DB00934 ;
ChemSpider	23719117 ;
UNII	2U1W68TROF;
KEGG	D02566 ;
ChEMBL	ChEMBL21731 ;
CompTox Dashboard (EPA)	DTXSID7045029 ;
ECHA InfoCard	100.030.532
Chemical and physical data
Formula	C20H23N
Molar mass	277.411 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12;
	InChI InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3/t15-,20+ ; Key:QSLMDECMDJKHMQ-GSXCWMCISA-N ;
	(what is this?) (verify)

Maprotiline, sold under the brand name Ludiomil among others, is a tetracyclic antidepressant (TeCA) that is used in the treatment of depression.^[5] It may alternatively be classified as a tricyclic antidepressant (TCA), specifically a secondary amine.^[5] In terms of its chemistry and pharmacology, maprotiline is closely related to such-other secondary-amine TCAs as nortriptyline and protriptyline and has similar effects to them,^[6]^[5] albeit with more distinct anxiolytic effects.^[7]^[8]^[9] Additionally, whereas protriptyline tends to be somewhat more stimulating and in any case is distinctly more-or-less non-sedating,^[10] mild degrees of sedation may be experienced with maprotiline.^[11]

^ Cite error: The named reference Elks2014 was invoked but never defined (see the help page).
^ Cite error: The named reference IndexNominum2000 was invoked but never defined (see the help page).
^ Cite error: The named reference Drugs.com was invoked but never defined (see the help page).
^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
^ ^a ^b ^c Cite error: The named reference LemkeWilliams2012 was invoked but never defined (see the help page).
^ Cite error: The named reference Zhou2013 was invoked but never defined (see the help page).
^ Guimarães FS, Zuardi AW, Graeff FG (January 1987). "Effect of chlorimipramine and maprotiline on experimental anxiety in humans". Journal of Psychopharmacology. 1 (3): 184–192. doi:10.1177/026988118700100305. PMID 22158980. S2CID 8444656.
^ Vinader-Caerols C, Martos AJ, Monleón S, Arenas MC, Parra A (2006). "Acute effects of maprotiline on learning, anxiety, activity and analgesia in male and female mice". Acta Neurobiologiae Experimentalis. 66 (1): 23–31. doi:10.55782/ane-2006-1584. PMID 16617674.
^ Pecknold JC, Familamiri P, McClure DJ, Elie R, Chang H (May 1985). "Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison". The Journal of Clinical Psychiatry. 46 (5): 166–171. PMID 2859273.
^ Brownell LG, Perez-Padilla R, West P, Kryger MH (1983). "The role of protriptyline in obstructive sleep apnea". Bulletin Européen de Physiopathologie Respiratoire. 19 (6): 621–4. PMID 6360257.
^ Holmberg G (May 1988). "Sedative effects of maprotiline and amitriptyline". Acta Psychiatrica Scandinavica. 77 (5): 584–6. doi:10.1111/j.1600-0447.1988.tb05171.x. PMID 3044007. S2CID 41977086.

[Elks2014-1] Cite error: The named reference Elks2014 was invoked but never defined (see the help page).

[IndexNominum2000-2] Cite error: The named reference IndexNominum2000 was invoked but never defined (see the help page).

[Drugs.com-3] Cite error: The named reference Drugs.com was invoked but never defined (see the help page).

[4] Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.

[LemkeWilliams2012-5] Cite error: The named reference LemkeWilliams2012 was invoked but never defined (see the help page).

[Zhou2013-6] Cite error: The named reference Zhou2013 was invoked but never defined (see the help page).

[7] Guimarães FS, Zuardi AW, Graeff FG (January 1987). "Effect of chlorimipramine and maprotiline on experimental anxiety in humans". Journal of Psychopharmacology. 1 (3): 184–192. doi:10.1177/026988118700100305. PMID 22158980. S2CID 8444656.

[8] Vinader-Caerols C, Martos AJ, Monleón S, Arenas MC, Parra A (2006). "Acute effects of maprotiline on learning, anxiety, activity and analgesia in male and female mice". Acta Neurobiologiae Experimentalis. 66 (1): 23–31. doi:10.55782/ane-2006-1584. PMID 16617674.

[9] Pecknold JC, Familamiri P, McClure DJ, Elie R, Chang H (May 1985). "Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison". The Journal of Clinical Psychiatry. 46 (5): 166–171. PMID 2859273.

[pmid6360257-10] Brownell LG, Perez-Padilla R, West P, Kryger MH (1983). "The role of protriptyline in obstructive sleep apnea". Bulletin Européen de Physiopathologie Respiratoire. 19 (6): 621–4. PMID 6360257.

[pmid3044007-11] Holmberg G (May 1988). "Sedative effects of maprotiline and amitriptyline". Acta Psychiatrica Scandinavica. 77 (5): 584–6. doi:10.1111/j.1600-0447.1988.tb05171.x. PMID 3044007. S2CID 41977086.

Maprotiline information

and 26 Related for: Maprotiline information

Maprotiline

Tetracyclic antidepressant

Norepinephrine reuptake inhibitor

Rilmenidine

List of psychiatric medications

MDMA

Sympathomimetic drug

ATC code N06

LSD

Ketamine

Cocaine

Clomipramine

List of antidepressants

Psilocybin

Tricyclic

Quetiapine

Hydroxyzine

Brazilian Controlled Drugs and Substances Act

Fluoxetine

Promethazine

Pirlindole

Phencyclidine

Chlorphenamine

Methylphenidate

Tizanidine

Trimipramine